Madrigal Pharmaceuticals Inc (MDGL) financials · rev $958.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Madrigal Pharmaceuticals Inc (MDGL) rev $958.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $958.4M | $180.1M |
| Cost of Revenue | N/A | $6.23M |
| Gross Profit | N/A | $173.9M |
| Operating Income | -$300.1M | -$497.9M |
| Net Income | -$288.3M | -$465.9M |
| EPS (Diluted) | -$12.85 | -$21.90 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.26B | $1.04B |
| Current Assets | $1.25B | $1.03B |
| Cash & Equivalents | $198.7M | $100.0M |
| Inventory | $74.8M | $34.1M |
| PP&E | $1.50M | $2.19M |
| Total Liabilities | $656.9M | $287.9M |
| Current Liabilities | $310.3M | $169.3M |
| Long-term Debt | $339.9M | $117.6M |
| Total Debt | $339.9M† | $117.6M† |
| Shareholders' Equity | $602.7M | $754.4M |
| Retained Earnings | -$2.09B | -$1.80B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$189.6M | -$455.6M |
| CapEx | $467.0K | $1.46M |
| Investing Cash Flow | $32.3M | -$274.4M |
| Financing Cash Flow | $256.0M | $735.1M |
| Net Change in Cash | $98.8M | $5.10M |
| Free Cash Flow | -$190.0M | -$457.0M |
FAQ
What is MDGL P/E and revenue?
Madrigal Pharmaceuticals Inc (MDGL) rev $958.4M.
What is MDGL revenue?
Madrigal Pharmaceuticals Inc last cached revenue is $958.4M (FY2025).
Is MDGL profitable?
Madrigal Pharmaceuticals Inc last cached net income is -$288.3M (FY2025).
What are MDGL total assets?
Madrigal Pharmaceuticals Inc last cached total assets are $1.26B (FY2025).
What is MDGL free cash flow?
Madrigal Pharmaceuticals Inc last cached free cash flow is -$190.0M (FY2025).
Not investment advice. Cached statements, not a live tape.